Search Results 3321-3330 of 25035 for oral

  1. Publications - Steven Attia, D.O. - Mayo Clinic

    Multicenter, open-label phase II study of daily oral regorafenib for chemotherapy-refractory, metastatic and locally advanced angiosarcoma. Ann Oncol. 2018 ...

  2. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric and Adolescent Medicine · Pediatric Otolaryngology · Physical Medicine ...

  3. Gregory A. Broderick, M.D. - Doctors and Medical Staff - Mayo Clinic

    He has served as an Oral Examiner for Urology Boards since 2020. Dr. Broderick was elected Trustee of the American Board of Urology (ABU). His six-year term ...

  4. Joel Streed | Mayo Clinic News Network - Page 93 of 170

    A rare genetic disorder, tuberous sclerosis, caused[...] By Joel Streed • August 9, 2016. Common Oral Problems: Mayo Clinic Radio Health Minute. In this Mayo ...

  5. Behcet disease - Diagnosis and treatment - Mayo Clinic

    This rare condition causes blood vessel swelling throughout the body. Symptoms depend on which parts of the body the condition affects.

  6. HPV infection - Symptoms & causes - Mayo Clinic

    Oral and upper respiratory sores, called lesions. Some HPV infections cause lesions on the tongue, tonsils or soft palate, or within the larynx and nose.

  7. Medtronic study with Personalized Closed Loop - Mayo Clinic

    Subject has taken any oral, injectable, or intravenous (IV) glucocorticoids within 8 weeks from time of visit 1, or plans to take any oral, injectable, or IV ...

  8. Study of Orally Administered AG-120 in Subjects with Advanced Hematologic Malignancies with an IDH1 Mutation - Mayo Clinic

    The first portion of the study is a dose escalation phase where cohorts of patients will receive ascending oral doses of AG-120 to determine maximum ...

  9. Open-label Extension Study of GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH) - Mayo Clinic

    Chronic use of oral anticoagulants (i.e., coumadin or novel oral anticoagulant [NOAC]). Chronic use of any prohibited medication. NOTE: Additional inclusion ...

  10. Publications - Robert Orenstein, D.O. - Mayo Clinic

    Tariq R, Laguio-Vila M, Tahir MW, Orenstein R, Pardi DS, Khanna S. Efficacy of oral vancomycin prophylaxis for prevention of Clostridioides difficile infection: ...